Cargando…
Severe fever and thrombocytopenia syndrome virus infection: Considerations for vaccine evaluation of a rare disease
Infection caused by the severe fever and thrombocytopenia syndrome virus (SFTSV) causes a hemorrhagic illness with a mortality between 20% and 40%. Initially recognized in 2009 in China, cases have additionally been documented in Japan and Korea although retrospective studies have documented seropre...
Autores principales: | Maslow, Joel N., Kwon, Jackie J., Mikota, Susan K., Spruill, Susan, Cho, Youngran, Jeong, Moonsup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816409/ https://www.ncbi.nlm.nih.gov/pubmed/31215838 http://dx.doi.org/10.1080/21645515.2019.1633875 |
Ejemplares similares
-
Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection
por: Lee, Hyojin, et al.
Publicado: (2017) -
Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021) -
Severe Fever with Thrombocytopenia Syndrome Virus in Ticks in the Republic of Korea
por: Kang, Jun-Gu, et al.
Publicado: (2022) -
Severe Fever with Thrombocytopenia Syndrome Virus in Dogs, South Korea
por: Kang, Jun-Gu, et al.
Publicado: (2019) -
Vaccine Development for Severe Fever with Thrombocytopenia Syndrome
por: Yoshikawa, Tomoki
Publicado: (2021)